INTERNATIONAL PATENT: TJ BIOPHARMA (SHANGHAI) CO., LTD., ABL BIO INC. FILES APPLICATION FOR "COMBINATION OF ANTI-CLAUDIN 18.2/ANTI-4-1BB ANTIBODIES AND SECOND THERAPEUTIC AGENT IN TREATMENT OF CANCER"

GENEVA, April 5 -- TJ BIOPHARMA (SHANGHAI) CO., LTD. (Rm802, 8F, 1Bld., West Tower, 88 Shangke Rd.Pudong New Area, Shanghai 201210), ABL BIO INC. (16, Daewangpangyo-ro 712beon-gil, Bundang-gu, Seongnam-siGyeonggi-do 13488) filed a patent application (PCT/CN2024/121653) for "COMBINATION OF ANTI-CLAUDIN 18.2/ANTI-4-1BB ANTIBODIES AND SECOND THERAPEUTIC AGENT IN TREATMENT OF CANCER" on Sep 27, 2024. With publication no. WO/2025/067400, the details related to the patent application was published on Apr 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIU, Xuejun (2275 Research Boulevard, Suit...